Konzernumbau und Glyphosat: Bayer ist „noch lange nicht am Ziel“
Der Pharma- und Agrarchemiekonzern kommt in seinen Rechtsstreitigkeiten rund um Glyphosat zwar voran – doch lastet der Monsanto-Kauf weiter mit Milliardensummen auf der Bilanz.
Results for “Monsanto”
7 stories found
Bayer Proposes $7.25 Billion Settlement for Monsanto's Roundup Cancer Claims
German pharmaceutical giant Bayer has proposed a $7.25 billion settlement to resolve claims in the US alleging that Monsanto's Roundup weedkiller causes cancer.
Bayer Offers $7.25 Billion to Settle Roundup Weedkiller Cancer Claims
Bayer has offered $7.25 billion to settle numerous legal claims alleging that its Roundup weedkiller, inherited from Monsanto, causes cancer.
Bayer Faces Billions in Losses Due to Glyphosate Lawsuits
Bayer reports significant financial losses, driven deep into the red by ongoing legal disputes related to its glyphosate-based products, stemming from its acquisition of Monsanto.
Trump Invokes Defense Act for Monsanto Chemicals, Designates Phosphorus as Critical Mineral
Former President Trump has invoked the Defense Act concerning Monsanto chemicals, leading to phosphorus being designated as a critical mineral, which is expected to impact Bayer and agribusiness ETFs.
Potentially Carcinogenic Herbicide Glyphosate Available for Purchase by Children in Serbia
A report from Nova ekonomija highlights that the potentially carcinogenic herbicide glyphosate, produced by Bayer and Monsanto, is easily accessible for purchase in Serbia, even by children. This comes as Bayer and Monsanto are reportedly settling lawsuits related to Roundup (glyphosate) for $7.2 billion.
Bayer Agrees to Billions in Roundup Lawsuit Settlements
German chemical giant Bayer has reached a proposed $7.25 billion settlement over lawsuits claiming that glyphosate in its Roundup weedkiller causes cancer.